and the Kogenate Previously Untreated Patient Group. Recombinant FVIII for the previously untreated patients with Hemophilia A. Safety, efficacy and development of inhibitors - Lusher, J M; Arkin, S; Abilgaard, C F; Schwartz, R S (N Engl J Med, 1993)